NASDAQ Framework: Option Care Health Inc.
1: Madison Small Cap Fund highlighted stocks like Option Care Health, Inc. (NASDAQ:OPCH) in its Q2 2024 investor letter. Option Care Health, Inc. (NASDAQ:OPCH) provides home and alternate site infusion services. The one-month return of Option Care Health, Inc. (NASDAQ:OPCH) was 5.83%, and its shares lost 7.47% of their value over the last 52 weeks. On July 19, 2024, Option Care Health, Inc. (NASDAQ:OPCH) stock closed at $30.33 per share with a market capitalization of $5.272 billion. View Source2: Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois. View Source3: Option Care Health, Inc. is an independent provider of home and alternate site infusion services. The Company’s infusion services include the clinical management of infusion therapy, nursing support and care coordination. It provides a therapy portfolio through its network of 93 full-service pharmacies and 84 stand-alone ambulatory infusion suites. It administers a wide variety of therapies and services, including anti-infectives infusion, heart failure, chronic inflammatory... View Source
Option Care Health Inc. (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company offers a comprehensive range of infusion therapies, including treatments for anti-infectives, heart failure, chronic inflammatory disorders, neurological disorders, and bleeding disorders, among others 456. With a network of 93 full-service pharmacies and 84 stand-alone ambulatory infusion suites, Option Care Health is dedicated to delivering high-quality clinical management, nursing support, and care coordination 7. The company has demonstrated significant revenue growth and is recognized for its strong market position, holding a 22% share in the fragmented in-home infusion market 89. Option Care Health is headquartered in Bannockburn, Illinois, and continues to expand its services through strategic initiatives and participation in various investor conferences 101112.
4: Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois. View Source5: Option Care Health, Inc. is an independent provider of home and alternate site infusion services. The Company’s infusion services include the clinical management of infusion therapy, nursing support and care coordination. It provides a therapy portfolio through its network of 93 full-service pharmacies and 84 stand-alone ambulatory infusion suites. It administers a wide variety of therapies and services, including anti-infectives infusion, heart failure, chronic inflammatory... View Source6: Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders among others. View Source7: Option Care Health, Inc. is an independent provider of home and alternate site infusion services. The Company’s infusion services include the clinical management of infusion therapy, nursing support and care coordination. It provides a therapy portfolio through its network of 93 full-service pharmacies and 84 stand-alone ambulatory infusion suites. It administers a wide variety of therapies and services, including anti-infectives infusion, heart failure, chronic inflammatory... View Source8: Option Care Health, Inc. (NASDAQ:OPCH) is not on our list of 31 Most Popular Stocks Among Hedge Funds. As per our database, 39 hedge fund portfolios held Option Care Health, Inc. (NASDAQ:OPCH) at the end of the first quarter which was 35 in the previous quarter. The commitment of the more than 7,500 team members to providing unmatched patient care and figuring out how to serve more patients is demonstrated by Option Care Health, Inc.'s (NASDAQ:OPCH) revenue growth of more than 12% in the first quarter. While we acknowledge the potential of Option Care Health, Inc. (NASDAQ:OPCH) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. View Source9: "Portfolio activity was de minimis in the second quarter. Option Care Health, Inc. (NASDAQ:OPCH) is the leading provider of in-home infusion and alternative site infusion services in the U.S., with a dominant 22% share. The market is heavily fragmented with CVS and Optum as the only other players with scale. In-home infusion is gaining share over infusion centers and clinicians and patients value in-home care due to patient convenience and better outcomes. We expect the penetration of the infusion market to continue along historical trends. As a business, Option Care is a prodigious free cash flow generator and it returns capital to its shareholders in the form of buybacks. We admire the company’s recurring revenue profile and its long growth runway. Our intrinsic value for the company is $42/share, which is derived from discounted cash flow analysis." View Source10: Option Care Health to Announce Second Quarter 2024 Financial Results and Host Conference Call GlobeNewswire Jul 8, 2024 8:05pm Option Care Health to Participate in Upcoming Investor Conferences GlobeNewswire May 16, 2024 8:05pm Option Care Health to Participate in the BofA Securities Health Care Conference GlobeNewswire Apr 29, 2024 8:05pm Amedisys agrees to merge with UnitedHealth, and terminates deal with Option Care Health MarketWatch Jun 26, 2023 1:09pm View Source11: Option Care Health to Announce Second Quarter 2024 Financial Results and Host Conference Call GlobeNewswire Jul 8, 2024 8:05pm Option Care Health to Participate in Upcoming Investor Conferences GlobeNewswire May 16, 2024 8:05pm Option Care Health to Participate in the BofA Securities Health Care Conference GlobeNewswire Apr 29, 2024 8:05pm Amedisys agrees to merge with UnitedHealth, and terminates deal with Option Care Health MarketWatch Jun 26, 2023 1:09pm View Source12: Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois. View Source
UNKNOWN
There is no information provided about the founders of Option Care Health Inc. or their current involvement in the company. The available facts do not mention the founders or their roles within the organization.
There is no information provided about the founders of Option Care Health Inc. or their current involvement in the company. The available facts do not mention the founders or their roles within the organization.
LOW RISK
Option Care Health Inc. (NASDAQ: OPCH) is considered low risk due to its strong financial performance and market position. The company has demonstrated significant revenue growth, with more than 12% growth in the first quarter 13. It is a prodigious free cash flow generator and returns capital to its shareholders through buybacks 14. Additionally, the company has a solid market capitalization of $5.272 billion as of July 19, 2024 15, and a price-to-earnings ratio of 19.60, indicating a healthy valuation 16. The company's recurring revenue profile and long growth runway further support its low-risk status 17.
Option Care Health Inc. (NASDAQ: OPCH) is considered low risk due to its strong financial performance and market position. The company has demonstrated significant revenue growth, with more than 12% growth in the first quarter 13. It is a prodigious free cash flow generator and returns capital to its shareholders through buybacks 14. Additionally, the company has a solid market capitalization of $5.272 billion as of July 19, 2024 15, and a price-to-earnings ratio of 19.60, indicating a healthy valuation 16. The company's recurring revenue profile and long growth runway further support its low-risk status 17.
13: Option Care Health, Inc. (NASDAQ:OPCH) is not on our list of 31 Most Popular Stocks Among Hedge Funds. As per our database, 39 hedge fund portfolios held Option Care Health, Inc. (NASDAQ:OPCH) at the end of the first quarter which was 35 in the previous quarter. The commitment of the more than 7,500 team members to providing unmatched patient care and figuring out how to serve more patients is demonstrated by Option Care Health, Inc.'s (NASDAQ:OPCH) revenue growth of more than 12% in the first quarter. While we acknowledge the potential of Option Care Health, Inc. (NASDAQ:OPCH) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. View Source14: "Portfolio activity was de minimis in the second quarter. Option Care Health, Inc. (NASDAQ:OPCH) is the leading provider of in-home infusion and alternative site infusion services in the U.S., with a dominant 22% share. The market is heavily fragmented with CVS and Optum as the only other players with scale. In-home infusion is gaining share over infusion centers and clinicians and patients value in-home care due to patient convenience and better outcomes. We expect the penetration of the infusion market to continue along historical trends. As a business, Option Care is a prodigious free cash flow generator and it returns capital to its shareholders in the form of buybacks. We admire the company’s recurring revenue profile and its long growth runway. Our intrinsic value for the company is $42/share, which is derived from discounted cash flow analysis." View Source15: Madison Small Cap Fund highlighted stocks like Option Care Health, Inc. (NASDAQ:OPCH) in its Q2 2024 investor letter. Option Care Health, Inc. (NASDAQ:OPCH) provides home and alternate site infusion services. The one-month return of Option Care Health, Inc. (NASDAQ:OPCH) was 5.83%, and its shares lost 7.47% of their value over the last 52 weeks. On July 19, 2024, Option Care Health, Inc. (NASDAQ:OPCH) stock closed at $30.33 per share with a market capitalization of $5.272 billion. View Source16: The stock’s market cap achieved a total value of $5.18 billion as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. The price-to-earnings ratio for Option Care Health Inc. (NASDAQ:OPCH) is 19.60. The price-to-earnings ratio is a method of assessing corporate values by comparing them to their per-share profit. Forward P/E stands at 21.73. Forward price-to-earnings is calculated using predicted earnings for the next financial year’s P/E determination. The stock has achieved an effective Price-to-Sales Ratio of 1.17 that mirrors the cost to be found for sales by the market. The firm managed a Price-to-Book ratio of 3.62, which equates the market value of a stock with its book value. View Source17: "Portfolio activity was de minimis in the second quarter. Option Care Health, Inc. (NASDAQ:OPCH) is the leading provider of in-home infusion and alternative site infusion services in the U.S., with a dominant 22% share. The market is heavily fragmented with CVS and Optum as the only other players with scale. In-home infusion is gaining share over infusion centers and clinicians and patients value in-home care due to patient convenience and better outcomes. We expect the penetration of the infusion market to continue along historical trends. As a business, Option Care is a prodigious free cash flow generator and it returns capital to its shareholders in the form of buybacks. We admire the company’s recurring revenue profile and its long growth runway. Our intrinsic value for the company is $42/share, which is derived from discounted cash flow analysis." View Source
NO
There is no information provided about Option Care Health Inc. launching any new product offerings. The available facts do not mention any new products being introduced by the company.
There is no information provided about Option Care Health Inc. launching any new product offerings. The available facts do not mention any new products being introduced by the company.
Option Care Health Inc. (NASDAQ: OPCH) has outlined a robust expansion strategy for 2024 through 2026, focusing on solidifying its leadership in the home and alternate site infusion services market. The company aims to leverage its dominant 22% market share in the fragmented in-home infusion sector by continuing to generate prodigious free cash flow and returning capital to shareholders through buybacks 18. Additionally, Option Care Health plans to enhance its service offerings and market reach by participating in various investor conferences and strategic initiatives, which are expected to drive further revenue growth and strengthen its market position 1920. The company's intrinsic value, derived from discounted cash flow analysis, is projected to be $42 per share, indicating a long growth runway and a commitment to delivering high-quality patient care 21.
18: "Portfolio activity was de minimis in the second quarter. Option Care Health, Inc. (NASDAQ:OPCH) is the leading provider of in-home infusion and alternative site infusion services in the U.S., with a dominant 22% share. The market is heavily fragmented with CVS and Optum as the only other players with scale. In-home infusion is gaining share over infusion centers and clinicians and patients value in-home care due to patient convenience and better outcomes. We expect the penetration of the infusion market to continue along historical trends. As a business, Option Care is a prodigious free cash flow generator and it returns capital to its shareholders in the form of buybacks. We admire the company’s recurring revenue profile and its long growth runway. Our intrinsic value for the company is $42/share, which is derived from discounted cash flow analysis." View Source19: Option Care Health to Announce Second Quarter 2024 Financial Results and Host Conference Call GlobeNewswire Jul 8, 2024 8:05pm Option Care Health to Participate in Upcoming Investor Conferences GlobeNewswire May 16, 2024 8:05pm Option Care Health to Participate in the BofA Securities Health Care Conference GlobeNewswire Apr 29, 2024 8:05pm Amedisys agrees to merge with UnitedHealth, and terminates deal with Option Care Health MarketWatch Jun 26, 2023 1:09pm View Source20: Option Care Health to Announce Second Quarter 2024 Financial Results and Host Conference Call GlobeNewswire Jul 8, 2024 8:05pm Option Care Health to Participate in Upcoming Investor Conferences GlobeNewswire May 16, 2024 8:05pm Option Care Health to Participate in the BofA Securities Health Care Conference GlobeNewswire Apr 29, 2024 8:05pm Amedisys agrees to merge with UnitedHealth, and terminates deal with Option Care Health MarketWatch Jun 26, 2023 1:09pm View Source21: "Portfolio activity was de minimis in the second quarter. Option Care Health, Inc. (NASDAQ:OPCH) is the leading provider of in-home infusion and alternative site infusion services in the U.S., with a dominant 22% share. The market is heavily fragmented with CVS and Optum as the only other players with scale. In-home infusion is gaining share over infusion centers and clinicians and patients value in-home care due to patient convenience and better outcomes. We expect the penetration of the infusion market to continue along historical trends. As a business, Option Care is a prodigious free cash flow generator and it returns capital to its shareholders in the form of buybacks. We admire the company’s recurring revenue profile and its long growth runway. Our intrinsic value for the company is $42/share, which is derived from discounted cash flow analysis." View Source